Eisai said it’s planning a rolling FDA submission next month to expand the use of its Biogen-partnered subcutaneous Alzheimer’s treatment, the latest effort to stoke

The FDA on Thursday approved Johnson & Johnson’s Darzalex injection for high-risk smoldering multiple myeloma, a condition in which people have abnormal cells that could

Over the last decade, FDA commissioners have generally steered clear from the nitty-gritty of drug applications, the opinions of drug review staff, or trying to

The pricing agreement between Novo Nordisk and Eli Lilly and the Trump administration on GLP-1 drugs for diabetes and obesity has arrived.

Since President Donald Trump began his emphatic push to reduce drug prices, a looming question has been how low he could bring down the price